Clinical Trial Update: Efficacy and Safety of 5 mg Sublingual Zolpidem vs 10mg Oral Zolpidem in the Induction and Maintenance of Sleep in Patients With Primary Insomnia [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing 5 mg sublingual zolpidem to 10 mg oral zolpidem for induction and maintenance of sleep in adults with primary insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Zolpidem (zolpidem)

Snippet

Sponsor: EMS | Conditions: Primary Insomnia | Phase 4 | Status: COMPLETED